Technology Portfolio
To advance our understanding of biological processes and accelerate discovery of new therapeutics, there is a need for advanced, high performance technologies for high-throughput functional analysis. Cellecta focuses on development of effective, advanced high-throughput screening technologies. Using lentiviral-based cloning and advanced library construction techniques, Cellecta has developed platforms for RNAi genome-wide genetic knockdown screening and large-scale functional peptide screening. The following pages review some of our core technologies and capabilities...
Genetic Screening using RNAi Technology
Designing Effective Pooled shRNA Libraries
shRNA Optimization for Pooled Library Screens
